Atea Pharmaceuticals, Inc. (AVIR)

Atea Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 14, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	274	283	254	401	743	3,452
Market Cap Growth	10.51%	11.19%	-36.48%	-46.08%	-78.48%	-
Enterprise Value	-102	-198	-338	-261	-96	3,522
Last Close Price	3.50	3.35	3.05	4.81	8.94	41.78
PE Ratio	-	-	-	-	6.13	-
PS Ratio	-	-	-	-	2.11	70.97
PB Ratio	0.78	0.65	0.46	0.63	1.05	6.30
P/TBV Ratio	0.76	0.65	0.46	0.63	1.05	6.30
P/FCF Ratio	-	-	-	-	-	11.63
P/OCF Ratio	-	-	-	-	-	11.63
EV/Sales Ratio	-	-	-	-	-	72.42
EV/FCF Ratio	-	-	-	-	-	11.87
Debt / Equity Ratio	0.00	0.00	0.00	0.01	0	-
Debt / EBITDA Ratio	-	-	-	-	0.00	-
Asset Turnover	-	-	-	-	0.43	0.11
Quick Ratio	18.87	24.44	18.04	35.00	13.44	2.71
Current Ratio	19.17	24.85	18.24	35.77	13.58	2.73
Return on Equity (ROE)	-32.38%	-33.88%	-22.74%	-17.16%	19.27%	-3.86%
Return on Assets (ROA)	-20.16%	-15.60%	-11.94%	-9.65%	10.57%	-1.56%
Return on Capital (ROIC)	-21.54%	-16.56%	-12.54%	-10.26%	13.75%	-2.43%
Return on Capital Employed (ROCE)	-	-	-	-	19.30%	-
Earnings Yield	-49.15%	-59.51%	-53.42%	-28.93%	16.31%	-0.32%
FCF Yield	-42.20%	-47.89%	-33.56%	-30.68%	-11.71%	8.60%
Buyback Yield / Dilution	-0.85%	-1.05%	-0.17%	5.67%	-308.70%	-113.98%

Updated May 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q